The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.
The 8p11 myeloproliferative syndrome (EMS), also called stem cell leukemia/lymphoma (SCLL), is a relatively rare condition characterized in its typical form by the occurrence, either simultaneously or sequentially, of a bcr/abl-negative myeloproliferative disorder and a lymphoma, usually a precursor T lymphoblastic lymphoma. The disease most often terminates in acute myeloid leukemia which is resistant to conventional chemotherapy. The defining cytogenetic abnormality, a translocation at the 8p11 locus, always involves the fibroblast growth factor 1 (FGFR1) gene. To date, eight partner genes have been identified in association with FGFR1 rearrangements. The most frequent FGFR1 translocation partner is the zinc finger gene ZNF198 located at 13q11. The t(8;13)(p11;q11) disrupts intron 8 of the FGFR1 gene and fuses proline-rich and zinc finger domains of the ZNF198 gene with the cytoplasmic tyrosine kinase domain of FGFR1. Oligomerization of the fusion protein occurs, with subsequent activation of downstream signal transduction pathways, culminating in neoplastic cell transformation. This review describes the historical development of the EMS/SCLL and outlines its cytogenetic abnormalities and molecular mechanisms with an illustrative case.
Goradia
Ami
A
Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. goradiaa@uphs.upenn.edu
Bayerl
Michael
M
Cornfield
Dennis
D
Br J Haematol. 1994 Apr;86(4):879-80
7918089
Blood. 2004 Jan 1;103(1):309-12
12969958
Cancer Genet Cytogenet. 1993 Jan;65(1):71-3
8431919
Cancer Genet Cytogenet. 2007 Mar;173(2):154-8
17321332
Int J Dev Biol. 2002;46(4):393-400
12141425
Cancer Cell. 2004 Mar;5(3):287-98
15050920
Br J Haematol. 2003 Apr;121(2):312-4
12694254
Genes Chromosomes Cancer. 1998 Feb;21(2):160-5
9491328
Br J Haematol. 2000 Nov;111(2):647-9
11122115
J Biol Chem. 1999 Sep 17;274(38):26922-30
10480903
Blood. 2001 Dec 15;98(13):3778-83
11739186
Neoplasia. 1999 Oct;1(4):349-55
10935490
Blood. 1997 Oct 15;90(8):3136-41
9376595
Acta Haematol. 2002;107(2):98-100
11919390
Am J Surg Pathol. 1992 Mar;16(3):236-45
1599015
Genes Chromosomes Cancer. 2004 May;40(1):78-83
15034873
Leukemia. 1998 Jun;12(6):999-1000
9639434
Blood. 1996 Feb 15;87(4):1658-9
8608264
Genes Chromosomes Cancer. 2001 Dec;32(4):302-10
11746971
Int J Hematol. 1999 Dec;70(4):278-82
10643154
Mol Cell Biol. 2001 Dec;21(23):8129-42
11689702
Blood. 2003 Jan 1;101(1):286-8
12393597
Eur J Haematol. 2006 Oct;77(4):349-54
16879608
Leuk Res. 2008 Jan;32(1):198-9
17555813
Nat Genet. 1998 Jan;18(1):84-7
9425908
Leukemia. 2002 Jul;16(7):1207-12
12094244
Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14479-84
15448205
Blood. 1995 Apr 15;85(8):2025-37
7718875
J Biol Chem. 2004 Feb 20;279(8):6666-73
14660670
Oncogene. 1998 Feb 19;16(7):945-9
9484786
Genes Chromosomes Cancer. 2007 Jul;46(7):635-43
17394134
Blood. 1998 Aug 15;92(4):1456-8
9694738
Acta Haematol. 1992;88(4):201-3
1292310
Blood. 2000 Jul 15;96(2):699-704
10887137
J Clin Oncol. 2000 Feb;18(3):547-61
10653870
Acta Haematol. 2002;107(2):95-7
11919389
Blood. 1997 Oct 15;90(8):3130-5
9376594
Cancer Genet Cytogenet. 1983 Aug;9(4):391-4
6575862
Blood. 1995 Apr 1;85(7):1881-7
7661940
Leukemia. 1995 Oct;9(10):1628-30
7564500
Genes Chromosomes Cancer. 2001 Oct;32(2):155-63
11550283
Leukemia. 2005 Jun;19(6):1005-9
15800673
Genes Chromosomes Cancer. 2005 Mar;42(3):320-5
15609342
Blood. 1999 Feb 15;93(4):1381-9
9949182
Exp Cell Res. 2006 Nov 15;312(19):3739-51
17027752
Blood. 2000 Mar 1;95(5):1788-96
10688839
Br J Haematol. 1994 Apr;86(4):876-8
7918088